Nicholas Michael Croft

Oct 6, 2023 | thelancet.com | Paediatric Gastroenterology |Feeding Disorders |Manoj Thakur |Nicholas Michael Croft

SummaryPrevious studies have demonstrated the tolerability and efficacy of multimatrix mesalamine in inducing and maintaining remission in adults with mild-to-moderate ulcerative colitis (UC). We evaluated the safety and efficacy of low-dose and high-dose once-daily multimatrix mesalamine in children and adolescents with mild-to-moderate UC or those in remission.